Probably not platinum based therapy because eligible subjects were be resistant to it (of course, rechallenge is possible). Maybe gemcitabine or paclitaxel.
As to concurrent treatment there is this tantalizing sentence on study details side of filing: Standard of care treatment, as medically appropriate and per local guidelines, outside of this study protocol can commence after the collection of the post-Kevetrin treatment biomarker samples (collected on Day 21±1 day)
News 
Market Data 
Discover 
